Aurograb

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameAurograb

Drug Alias NameAurograb

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment > Single-chain FV antibody fragment (scFv)Biologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsStaphylococcal Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited Kingdom

CombinationsNo

Global Highest StatusPending (Phase 3 Clinical)

Highest Status in ChinaN/A

Originator CompaniesNeutec Pharma Ltd

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesNeutec Pharma

Active IndicationsN/A

Inactive IndicationsStaphylococcal Infections

Other Information

ATC CodeN/A